To homepage
1M+ patient inquiries
32+ countries
3,323 partner clinics
13,325 certified doctors

What's the Cost of Myeloma Diagnosis and Treatment in India?

Myeloma treatment cost in India varies by disease stage, drug plan and hospital type. Extended blood analysis ranges from AUD $60 to AUD $170; CAR-T for multiple myeloma costs Price on request to Price on request . Costs also depend on treatment duration, medicines and whether transplant care is needed. Compared with Australia and other Western countries, patients may save roughly 40โ€“60%. Delhi, Gurgaon and Chennai are key cities to compare.

  • Biochemical blood analysis: AUD $60 โ€“ AUD $140
  • Consultation with a haematologist: AUD $60 โ€“ AUD $90
  • Plasmapheresis: AUD $1,700 โ€“ AUD $3,000

Bookimed Expert Insight: Australians considering transplant assessment can compare HCG Manavata Cancer Centre in Nashik. Haematologist Dr Girish Badarkhe specialises in multiple myeloma and performs allogeneic and haploidentical transplants. The centre reports 65+ bone marrow transplants in 2.5 years. Its National Accreditation Board for Hospitals and Healthcare Providers (NABH) accreditation means its hospital standards are independently assessed.

IndiaThailandTurkey
Therapeutic Apheresisโ‰ˆ AUD $1,400from AUD $8,900from AUD $6,800
Plasmapheresisโ‰ˆ AUD $1,700โ‰ˆ AUD $1,800from AUD $4,800
Plasma Exchangeโ‰ˆ AUD $2,700โ‰ˆ AUD $4,200โ‰ˆ AUD $2,700
DFPP Plasmapheresisโ‰ˆ AUD $1,400from AUD $5,900โ‰ˆ AUD $680
Data verified by Bookimed as of November 2026, based on patient requests and official quotes from 80 clinics worldwide. Median costs are based on real invoices (2025โ€“2026) and updated monthly. Actual prices may vary.

Your Benefits and Guarantees with Bookimed

Transparent Prices & Flexible Installments

No hidden fees โ€“ just official clinic prices. Pay at the clinic for Myeloma treatment and use a flexible instalment plan if needed.

Verified Clinics & Doctors Only

Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Myeloma treatment and have the necessary licenses to serve international patients worldwide.

Free 24/7 Assistance

Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Myeloma treatment journey.

assistant avatar
Why we?

Your personal Bookimed medical coordinator

  • Supports you at every stage
  • Helps choose the right clinic and doctor
  • Ensures quick and convenient access to information

Best Myeloma Treatment Centres in India for Australians: 10 Verified Options and AUD Prices

Get a Medical Assessment for Myeloma in India: Consult with Experienced Doctors Now

View all Doctors
Prakash Pandit
verified

Prakash Pandit

35 years of experience

Dr. Prakash Pandit specializes in advanced radiation therapies for myeloma at HCG Manavata Cancer Centre.

  • Expert in Tomotherapy-H, Linear Accelerator, and Brachytherapy
  • MD in Radiation Oncology with extensive clinical experience
  • Consultant at a leading cancer treatment center
Sudarshan Pandit
verified

Sudarshan Pandit

11 years of experience

Dr. Sudarshan Pandit is a hematologist and clinical oncologist at HCG Manavata Cancer Centre. He specializes in hemato-oncology and bone marrow transplantation. He treats blood cancers such as leukemia, lymphoma, and myeloma, and manages non-cancerous conditions including aplastic anemia and thrombocytopenia.

  • Performs bone marrow transplants for malignant and benign blood disorders.
  • Treats Hodgkinโ€™s and Non-Hodgkinโ€™s lymphoma.
  • Works at HCG Manavata, an NABH and NABL accredited cancer specialty hospital.
  • Practices in a facility that treats over 75,000 patients annually.
Girish Badarkhe
verified

Girish Badarkhe

16 years of experience

16 years treating multiple myeloma with expertise in bone marrow transplants โ€“ Dr. Badarkhe combines hematology and oncology knowledge for comprehensive care.

  • Specializes in leukemia and myeloma at HCG Manavata Cancer Centre
  • Fellowship-trained in Clinical Hematology at Medical College, Calcutta
  • Awarded for professionalism and hard work in hematology
  • MBBS from Grant Medical College and Sir JJ Hospital
Deenadayalan Munirathnam
verified

Deenadayalan Munirathnam

The doctor is a pediatric hematologist-oncologist with a specialization in bone marrow transplantation. They have extensive experience in treating complex blood disorders and cancers in children. Their clinical focus includes the management of pediatric leukemia, lymphoma, and other hematologic malignancies. The doctor is recognized for their expertise in performing bone marrow transplants and has contributed to advancements in pediatric oncology through clinical research and innovation.

Share this content

Video Stories from Bookimed Patients

Dayana
I combined my vacation in Antalya with a check-up.
Procedure: Female check-up
Igor
It was great! Transfers, accommodation, treatmentโ€”all included.
Procedure: Dental Implant
Marina
Bookimed did everything for me. I didn't have to worry about anything.
Procedure: Female check-up
Updated: 18/11/2026
Authored by
Anna LeonovaAnna Leonova
Anna Leonova
Head of Content Marketing Team
A certified medical writer with 10+ years of experience, developed Bookimedโ€™s trusted content, backed by a Masterโ€™s in Philology and medical expert interviews worldwide.
Fahad Mawlood
Fahad Mawlood
Medical Editor & Data Scientist
General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.
Fahad Mawlood Linkedin
This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.

Expert Overview about Myeloma Treatment in India

These FAQs come from real patients seeking medical assistance through Bookimed. Answers are given by experienced medical coordinators and trusted clinic representatives.

Which are the best hospitals for myeloma treatment in India?

India hosts several high-performing hospitals for myeloma treatment. These include JCI-accredited facilities like Apollo Hospital Indraprastha in Delhi and Artemis Hospitals in Gurgaon. These centres specialise in chemotherapy, immunotherapy, and bone marrow transplants. Most major Indian oncology hubs provide multi-disciplinary care under one roof.

  • Clinical accreditation: Apollo Hospital and Artemis Hospitals hold JCI accreditation for quality and safety.
  • Diagnostics: Clinics use Sentinel lymph node biopsy and haematologist consultations for staging.
  • Specialist expertise: Dr Girish Badarkhe at HCG Manavata Cancer Centre performs complex haploidentical transplants.
  • Institutional scale: Medanta Hospital in Gurgaon houses 1,600 beds and is NABH-accredited.

Bookimed Expert Insight: Many patients focus on Delhi or Mumbai. However, centres in Nashik like HCG Manavata Cancer Centre serve 75,000 patients each year. This high volume often leads to faster diagnostic turnaround times. It was also the first NABH-accredited cancer care facility in Maharashtra.

Patient Consensus: Patients note that Mumbai and Delhi hospitals have extremely dedicated doctors. These doctors manage over 1,000 transplants. They recommend gathering full medical records before seeking second opinions from these experienced haematologists.

What are the primary treatments for multiple myeloma in India?

Multiple myeloma treatment in India focuses on induction therapy and autologous stem cell transplants. Advanced immunotherapy is also used. Patients access targeted protocols using proteasome inhibitors and monoclonal antibodies. Specialist centres like HCG Manavata Cancer Centre and Artemis Hospitals provide these treatments. They follow international JCI and NABH quality standards.

  • Induction therapy: Doctors use drug combinations to reduce cancer cell count before further treatment.
  • Stem cell transplant: Eligible patients often receive autologous, allogeneic, or haploidentical bone marrow transplants.
  • Advanced immunotherapy: CAR T-cell therapy is available for complex or relapsed blood cancer cases.
  • Precision radiation: Systems like Tomotherapy-H and Linear Accelerators deliver targeted radiation to bone lesions.
  • Diagnostic monitoring: Specialists use PET-CT and MRI scans to track treatment response and staging.

Bookimed Expert Insight: India has become a hub for complex haematology. This is due to major networks like Manipal and Apollo managing over 1,000,000 patients each year. Because of this volume, specialists like Dr Girish Badarkhe gain experience in rare haploidentical transplants. These procedures are often harder to access in smaller regional hospitals elsewhere.

Patient Consensus: Patients in India often start with a four-drug induction regimen including Bortezomib and Dexamethasone. Many note that lowering steroid doses helps manage side effects during stem cell transplant preparation.

Is CAR-T cell therapy available for myeloma in India?

CAR-T cell therapy is available for myeloma in India at major oncology hospitals. Indian centres use indigenous CAR-T technologies and international protocols for refractory blood cancers. Doctors such as Dr Girish Badarkhe at HCG Manavata Cancer Centre perform these procedures. They treat complex cases.

  • Clinical applications: Specialists use CAR-T for blood cancers that have not responded to standard treatments.
  • Indigenous technology: India uses homegrown CAR-T programs, making cellular therapy more accessible and affordable.
  • Specialist expertise: Dr Girish Badarkhe performs CAR-T therapy within NABH-accredited facilities specialising in haematology.
  • Supporting treatments: Clinics offer related procedures including allogeneic and haploidentical bone marrow transplants where necessary.

Bookimed Expert Insight: Indian clinics such as HCG Manavata Cancer Centre have a distinct advantage. They combine CAR-T with TomoTherapy-H and Versa HD radiation. This multi-modal approach manages complex myeloma cases more effectively than single-therapy protocols. This level of integrated care is often unavailable at smaller regional centres.

Patient Consensus: Patients in India find the three-month recovery period manageable. It feels less intense than traditional stem cell transplants. They highlight the importance of preparing for low immune function and potential IgG infusions. These are common after the CAR-T cells are administered.

Are the latest drugs and targeted therapies available for myeloma treatment in India?

Leading Indian medical centres provide the latest myeloma treatments. These include CAR T-cell therapy and immunotherapies like daratumumab. Major hospitals in Delhi, Bengaluru and Chennai specialise in these targeted protocols. Australian patients often access clinical trials for emerging agents like mezigdomide.

  • Specialised care: Fortis Hospital Gurugram and HCG Manavata Cancer Centre host dedicated myeloma units.
  • Advanced immunotherapy: Centres routinely use four-drug regimens including daratumumab for relapsed and new cases.
  • Cellular therapy: Specialists like Dr Girish Badarkhe offer CAR T-cell therapy for refractory cancers.
  • Precision radiation: 4D radiotherapy and TomoTherapy-H target tumours while protecting healthy patient tissue.

Bookimed Expert Insight: India ranks 6th globally for medical requests on Bookimed. Top centres like Manipal Hospitals serve over 2,000,000 patients annually. This massive case volume allows Indian specialists to manage complex myeloma cases with highly refined protocols. Australian patients benefit from this deep clinical experience in major metropolitan hubs.

Patient Consensus: Patients note that standard quadruplet therapy is readily available in India. Clinical trials provide a vital pathway to access newer targeted medications at reduced costs. Seeking a compassionate specialist early is essential for managing side effects and long-term recovery.

How long does the myeloma treatment process in India take?

Myeloma treatment in India typically lasts 6 to 7 months for the main phases. Initial diagnostics take 5 to 7 days. This is followed by 3 to 6 months of induction chemotherapy. A stem cell transplant requires 3 to 4 weeks of inpatient care.

  • Diagnostic phase: Haematologists use PET-CT scans and biopsies, usually completed within 1 week.
  • Induction therapy: Outpatient chemotherapy or immunotherapy cycles last approximately 3 to 6 months.
  • Transplant stay: Autologous stem cell transplants involve 3 to 4 weeks of hospitalisation.
  • Recovery period: Initial recovery takes 2 to 3 weeks followed by outpatient maintenance.

Bookimed Expert Insight: Indian clinics like HCG Manavata Cancer Centre and Apollo Hospital handle massive patient volumes. This experience allows specialists like Dr Girish Badarkhe to manage complex haploidentical transplants. Their high caseload often leads to faster diagnostic turnaround times compared to smaller facilities.

Patient Consensus: Patients note significant blood report improvements after starting therapy in India. These improvements appear within 4 to 6 weeks. The first 6 weeks post-transplant are physically taxing. However, most patients regain their stamina and reach remission by the 6-month mark.

Can I get a second opinion from a specialist in India for myeloma?

Patients can obtain expert second opinions for myeloma from leading Indian haematologists. Specialist centres provide reviews for complex cases, including refractory blood cancers and transplant eligibility. Consultations with haematologists typically cost between A$60 and A$70. Many facilities offer virtual reviews of lab results and bone marrow biopsies.

  • Accredited facilities: JCI and NABH-accredited centres like Manipal Hospitals serve 2,000,000 patients annually.
  • Advanced therapies: Specialists provide second opinions on CAR T-cell therapy and haploidentical stem cell transplants.
  • Precision diagnostics: Centres use PET-CT and US-FDA-audited research protocols to confirm myeloma stages.
  • Expert specialists: Doctors like Dr Girish Badarkhe at HCG Manavata have over 10 years' experience.

Bookimed Expert Insight: Indian specialists often manage exceptionally high patient volumes, which is vital for rare myeloma subtypes. For instance, Apollo Hospitals serves over 1,000,000 international patients annually. These massive datasets allow haematologists to identify patterns in treatment resistance. Centres with lower volumes might miss these patterns.

Patient Consensus: Patients note that second opinions in India help clarify if autologous transplants are necessary. These procedures are intensive. Virtual consultations are a popular way to access specialists early, before bone damage occurs.

What kind of support is available for international patients seeking myeloma treatment in India?

International patients in India benefit from dedicated medical coordination and visa assistance. They also receive specialised logistical support at JCI-accredited facilities. Specialised desks manage airport transfers and local accommodation. Multilingual staff and personal coordinators at clinics like Aster CMI Hospital simplify communication. They assist during complex bone marrow transplant procedures.

  • Clinic accreditation: Major hubs like Artemis Hospitals and Apollo Hospital Indraprastha hold JCI certification.
  • Logistical assistance: Aster CMI Hospital provides free airport transfers and dedicated personal coordinators for patients.
  • Dietary support: Global Hospital Mumbai offers specialised meals tailored to specific religious and dietary requirements.
  • Language services: International patients at Manipal Goa Hospital have access to professional interpreters and accommodations.
  • Research access: HCG Manavata Cancer Centre features a research institute audited by the US-FDA.

Bookimed Expert Insight: Clinics in Mumbai and Bengaluru often achieve higher success. They do so by combining standard induction therapy with advanced diagnostics. Manipal Goa Hospital uses IBM Watson for Oncology with 96% accuracy for lung cancer. This reflects the high-tech diagnostic support available for complex myeloma staging.

Patient Consensus: Patients value the clinical expertise in stem cell therapy. They also find the induction protocols align closely with Australian and international standards. Support for housing and visas is available. However, patients note it is important to proactively request palliative care for side effect management.

Get a free consultation

Select the best way to contact you